Market Research Report
Asia Pacific Spinal Cord Stimulation Devices Market (2019-2025)
|Asia Pacific Spinal Cord Stimulation Devices Market (2019-2025)|
Published: September 30, 2019
Content info: 72 Pages
Delivery time: 1-2 business days
The Asia Pacific Spinal Cord Stimulation Devices Market would witness market growth of 9.3% CAGR during the forecast period (2019-2025). The growing geriatric population and favorable reimbursement and insurance approval measures are key variables influencing the rise of this industry. Strict governmental approvals and high device costs, however, will hamper this market's growth. Besides, the introduction of new methods in minimally invasive surgery will generate profitable possibilities for core participants in the market.
Stimulation of the spinal cord has been in therapy use for almost 50 years. Specifically, the understanding of how to use it properly and the technology's sophistication has significantly progressed. High quality, randomized, comparative clinical trials in the treatment of clients with refractory neuropathic pain have shown unequivocal clinical and price-effectiveness. Stimulation of the spinal cord can also be used in ischaemic pain syndromes, like angina pectoris, chronic critical limb ischemia, and other syndromes of visceral pain including chronic painful bladder syndrome, pancreatitis, and abdominal pain.
Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Australia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.